{
    "1653706561112494080": {
        "author_id": "194037150",
        "created_at": "2023-05-03T10:22:23.000Z",
        "edit_history_tweet_ids": [
            "1653706561112494080"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 23,
                    "normalized_text": "Jeldrick",
                    "probability": 0.5091,
                    "start": 16,
                    "type": "Person"
                },
                {
                    "end": 255,
                    "normalized_text": "Germany",
                    "probability": 0.9481,
                    "start": 249,
                    "type": "Place"
                },
                {
                    "end": 274,
                    "normalized_text": "Asif",
                    "probability": 0.2673,
                    "start": 271,
                    "type": "Place"
                },
                {
                    "end": 288,
                    "normalized_text": "Novo Nordisk",
                    "probability": 0.462,
                    "start": 277,
                    "type": "Organization"
                }
            ]
        },
        "id": "1653706561112494080",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 47,
            "like_count": 0,
            "quote_count": 0,
            "reply_count": 0,
            "retweet_count": 0
        },
        "text": "@RBFried18 Dear Jeldrick, we are sorry to hear that you are not able to access the medicine you need. Due to legal regulations, we are not allowed to discuss our products on social media. I encourage you to follow the guidance from my colleagues in Germany.\nBest wishes,\nAsif, Novo Nordisk"
    }
}